Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07351123 · ClinicalTrials.gov registry record
Assessment of Treatment Variability for Pelvic Ring Fragility Fractures
A clinical trial, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 120
- Enrollment target
NCT07351123: Recruiting study, sponsored by University of Maryland, Baltimore.
NCT07351123 is a clinical trial that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07351123 is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
Study Summary
Fragility fractures of the pelvic ring are a common injury associated with poor patient outcomes and high healthcare costs. Management of these injuries is evolving with increasing frequency of operative stabilization of the pelvic ring, despite a lack of evidence supporting operative versus nonoperative treatment. This multicenter prospective cohort study will evaluate 120 patients to determine the feasibility of a randomized controlled trial comparing operative and nonoperative treatment, by evaluating patient willingness to enroll in a trial, surgeon willingness to randomize their patients' treatment, and the completeness of data collection.
Primary Outcome
Willingness to enroll in a trial will be assessed as a binary variable with the central three choices representing that the participant is willing to have their treatment randomized.
Interventions
- PROCEDURE Surgical stabilization of pelvic fracture
- OTHER Closed treatment of pelvic fracture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-05-25 |
| Est. Completion | 2027-09-30 |
What NCT07351123 shows while recruiting
NCT07351123 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Surgical stabilization of pelvic fracture is the first listed.
NCT07351123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07351123 about?
NCT07351123 is a clinical study titled "Assessment of Treatment Variability for Pelvic Ring Fragility Fractures". Fragility fractures of the pelvic ring are a common injury associated with poor patient outcomes and high healthcare costs. Management of these injuries is evolving with increasing frequency of operative stabilization of the pelvic ring, despite a lack of evidence supporting operative versus nonoper...
What is the current status of trial NCT07351123?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2026-05-25. Estimated completion is 2027-09-30.
What interventions are being tested in trial NCT07351123?
The interventions under investigation include: Surgical stabilization of pelvic fracture (PROCEDURE), Closed treatment of pelvic fracture (OTHER).
Who is sponsoring clinical trial NCT07351123?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI